AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List

15.12.25 02:00 Uhr

Werte in diesem Artikel
Aktien

189,60 EUR -1,60 EUR -0,84%

SINGAPORE, Dec. 15, 2025 /PRNewswire/ -- AbbVie ASEAN has been ranked #15 in the inaugural Fortune Best Companies to Work For Southeast Asia 2025 list, in partnership with Great Place To Work®, highlighting workplaces across Singapore, Malaysia, Thailand and the Philippines.

This honor builds on AbbVie's inclusion in the 2025 Best Workplaces in Asia™ list earlier this year – recognition that spans a wide geographic area assessed by Great Place to Work, covering markets across Asia and the Middle East. It underscores the strength, consistency and quality of our employee experience across roles and genders in these markets. The Fortune list is a highly selective recognition that spotlights companies with truly exceptional workplace cultures.

AbbVie places trust, collaboration and belonging at the center of how teams work together. These behaviors foster an environment where employees feel valued, empowered and inspired to bring their best selves to work, driving engagement and innovation. By prioritizing its people, AbbVie builds stronger teams and delivers greater impact for the patients and communities it serves.

"As a team spanning Singapore, Malaysia, Thailand and the Philippines, being recognized among the best workplaces in Southeast Asia affirms the commitment we make every day to listen, support and enable our people to thrive," said Rama Vela, General Manager, AbbVie ASEAN — a sub‑region of Asia comprising Singapore, Malaysia, Thailand and the Philippines. "Our people are at the heart of everything we do. This recognition reflects how purpose, inclusion and focus on wellbeing ripple outward – touching not just our teams, but patients and communities across Southeast Asia."

The Fortune Southeast Asia ranking is based on employee feedback collected through the GPTW Trust Index™ survey — the same survey used for GPTW Certification — and culture audits evaluating trust, leadership effectiveness, innovation and inclusivity. While certification confirms a company meets global standards for a great workplace, the Fortune listing recognizes only the top performers in the region, setting the benchmark for Southeast Asia.

The full list can be found here.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology, neuroscience and eye care – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

About Great Place To Work

As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform helps companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces List. 

Follow Great Place To Work on LinkedIn, X, and Instagram or visit greatplacetowork.com and sign up for the newsletter to learn more.

(PRNewsfoto/AbbVie)

Cision View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/abbvie-ranked-15-in-the-inaugural-fortune-100-best-companies-to-work-for-southeast-asia-2025-list-302640045.html

SOURCE AbbVie

In eigener Sache

Übrigens: AbbVie und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf AbbVie

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf AbbVie

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu AbbVie Inc

Wer­bung

Analysen zu AbbVie Inc

DatumRatingAnalyst
27.06.2019AbbVie Peer PerformWolfe Research
29.04.2019AbbVie Market PerformBMO Capital Markets
26.12.2018AbbVie BuyStandpoint Research
02.02.2018AbbVie UnderperformBMO Capital Markets
25.09.2017AbbVie NeutralUBS AG
DatumRatingAnalyst
29.04.2019AbbVie Market PerformBMO Capital Markets
26.12.2018AbbVie BuyStandpoint Research
23.10.2015AbbVie BuyUBS AG
17.04.2015AbbVie OutperformBMO Capital Markets
06.01.2015AbbVie BuyUBS AG
DatumRatingAnalyst
27.06.2019AbbVie Peer PerformWolfe Research
25.09.2017AbbVie NeutralUBS AG
15.03.2016AbbVie HoldDeutsche Bank AG
01.12.2015AbbVie Equal WeightBarclays Capital
DatumRatingAnalyst
02.02.2018AbbVie UnderperformBMO Capital Markets

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für AbbVie Inc nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen